To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis
Ludesi AB has announced that Mitsubishi Pharma in Yokohama, Japan after thorough testing has selected Ludesi for its image analysis processing of 2D gels.
Mitsubishi Pharma Corporation has contracted Ludesi for image analysis of twodimensional protein gels (2D gels), one of the fundamental technologies in proteomics.
"We are proud that Mitsubishi Pharma has selected Ludesi’s technology for 2D gel image analysis, and we look forward to working together in the years to come," commented Ludesi’s CEO Ola Forsstrom-Olsson.
"It is an honor to serve Mitsubishi Pharma’s skilled scientists with top-notch quality in this important proteomics technology."
Experts at Mitsubishi Pharma Corporation tested Ludesi’s system thoroughly and concluded that Ludesi’s offering provided an increased quality and reliability compared to other software systems on the market.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
